Yuko Yamagata

601 total citations
20 papers, 476 citations indexed

About

Yuko Yamagata is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yuko Yamagata has authored 20 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Yuko Yamagata's work include Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Ion Transport and Channel Regulation (4 papers) and Ion channel regulation and function (4 papers). Yuko Yamagata is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers), Ion Transport and Channel Regulation (4 papers) and Ion channel regulation and function (4 papers). Yuko Yamagata collaborates with scholars based in Japan, Canada and Nigeria. Yuko Yamagata's co-authors include Toshiyuki Yamagata, Yuji Higashimoto, André Dagenais, Yves Berthiaume, Morihiro Okada, Tadashi Ishiguchi, Emmanuelle Brochiero, Chantal Massé, Yoshiaki Minakata and Hidekazu Itoh and has published in prestigious journals such as PLoS ONE, Scientific Reports and CHEST Journal.

In The Last Decade

Yuko Yamagata

19 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Yamagata Japan 11 221 159 95 80 54 20 476
Monica Boita Italy 15 145 0.7× 43 0.3× 175 1.8× 92 1.1× 40 0.7× 32 487
Astrid Doerner United States 5 120 0.5× 96 0.6× 116 1.2× 118 1.5× 48 0.9× 8 363
Patricia P. Ogger United Kingdom 9 209 0.9× 169 1.1× 38 0.4× 213 2.7× 22 0.4× 13 530
Fotios Drakopanagiotakis Greece 11 422 1.9× 77 0.5× 154 1.6× 46 0.6× 38 0.7× 33 587
Kiran Dhillon Canada 6 40 0.2× 101 0.6× 52 0.5× 126 1.6× 42 0.8× 8 415
Bruno Iovene Italy 8 529 2.4× 99 0.6× 123 1.3× 31 0.4× 43 0.8× 23 607
Karen J. Keeran United States 12 89 0.4× 122 0.8× 184 1.9× 175 2.2× 28 0.5× 20 429
C. M. Doerschuk United States 9 174 0.8× 56 0.4× 83 0.9× 137 1.7× 71 1.3× 12 451
Hansvin Bunjhoo China 10 221 1.0× 63 0.4× 160 1.7× 92 1.1× 55 1.0× 18 434
Berivan Bıtık Türkiye 12 69 0.3× 107 0.7× 46 0.5× 83 1.0× 89 1.6× 37 468

Countries citing papers authored by Yuko Yamagata

Since Specialization
Citations

This map shows the geographic impact of Yuko Yamagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Yamagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Yamagata more than expected).

Fields of papers citing papers by Yuko Yamagata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Yamagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Yamagata. The network helps show where Yuko Yamagata may publish in the future.

Co-authorship network of co-authors of Yuko Yamagata

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Yamagata. A scholar is included among the top collaborators of Yuko Yamagata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Yamagata. Yuko Yamagata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Okuyama, Kohei, Yasuyuki Michi, Hirofumi Tomioka, et al.. (2021). Epithelial-Myoepithelial Carcinoma of the Minor Salivary Glands: Case Series with Comprehensive Review. Diagnostics. 11(11). 2124–2124. 6 indexed citations
3.
Tomioka, Hirofumi, Yuko Yamagata, Yu Oikawa, et al.. (2021). Risk factors for distant metastasis in locoregionally controlled oral squamous cell carcinoma: a retrospective study. Scientific Reports. 11(1). 5213–5213. 20 indexed citations
4.
Yamagata, Yuko, Hirofumi Tomioka, Kei Sakamoto, et al.. (2017). CD163-Positive Macrophages Within the Tumor Stroma Are Associated With Lymphangiogenesis and Lymph Node Metastasis in Oral Squamous Cell Carcinoma. Journal of Oral and Maxillofacial Surgery. 75(10). 2144–2153. 47 indexed citations
5.
Yamagata, Toshiyuki, Yuko Yamagata, Tsunahiko Hirano, et al.. (2008). The regulation of amiloride-sensitive epithelial sodium channels by tumor necrosis factor-alpha in injured lungs and alveolar type II cells. Respiratory Physiology & Neurobiology. 166(1). 16–23. 32 indexed citations
6.
Higashimoto, Yuji, Yuko Yamagata, Morihiro Okada, et al.. (2008). [Systemic inflammation in COPD and asthma: similarities and differences].. PubMed. 46(6). 443–7. 2 indexed citations
7.
Yamagata, Toshiyuki, Hisatoshi Sugiura, Tomonori Yokoyama, et al.. (2007). Overexpression of CD-11b and CXCR1 on Circulating Neutrophils. CHEST Journal. 132(3). 890–899. 30 indexed citations
8.
Higashimoto, Yuji, Yuko Yamagata, Morihiro Okada, et al.. (2007). Systemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differences. Respirology. 13(1). 128–133. 70 indexed citations
9.
Higashimoto, Yuji, Yuko Yamagata, & Hidekazu Itoh. (2006). Complex Effect of Adenovirus Early Region Proteins on Innate Immune System. Inflammation & Allergy - Drug Targets. 5(4). 229–237. 8 indexed citations
10.
Akamatsu, Keiichiro, T Takahashi, Kouji Miura, et al.. (2006). Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal β2-agonist. Pulmonary Pharmacology & Therapeutics. 20(6). 701–707. 6 indexed citations
11.
Hirano, Tsunahiko, Yuko Yamagata, Tomohiro Ichikawa, et al.. (2006). Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline. Thorax. 61(9). 761–766. 19 indexed citations
12.
Yamagata, Toshiyuki, Yuko Yamagata, Masanori Nakanishi, et al.. (2005). Angioimmunoblastic lymphadenopathy with dysproteinaemia accompanied by pleural effusion. Respirology. 10(1). 124–127. 6 indexed citations
13.
Higashimoto, Yuji, Yuko Yamagata, Tadashi Ishiguchi, et al.. (2005). Adenoviral E1A Suppresses Secretory Leukoprotease Inhibitor and Elafin Secretion in Human Alveolar Epithelial Cells and Bronchial Epithelial Cells. Respiration. 72(6). 629–635. 10 indexed citations
14.
Yamagata, Toshiyuki, Yuko Yamagata, Chantal Massé, et al.. (2005). Modulation of Na+transport and epithelial sodium channel expression by protein kinase C in rat alveolar epithelial cells. Canadian Journal of Physiology and Pharmacology. 83(11). 977–987. 16 indexed citations
15.
Higashimoto, Yuji, M Ohata, Yuko Yamagata, et al.. (2005). Effect of the adenovirus E1A gene on nitric oxide production in alveolar epithelial cells. Clinical Microbiology and Infection. 11(8). 644–650. 3 indexed citations
16.
Higashimoto, Yuji, Yuko Yamagata, Takekazu Iwata, et al.. (2005). Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients. European Respiratory Journal. 25(5). 885–890. 49 indexed citations
17.
Dagenais, André, Yuko Yamagata, Toshiyuki Yamagata, et al.. (2004). Downregulation of ENaC activity and expression by TNF-α in alveolar epithelial cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 286(2). L301–L311. 117 indexed citations
18.
Yamagata, Toshiyuki, Yuko Yamagata, Masanori Nakanishi, et al.. (2004). A Case of Primary Lung Cancer Producing Alpha‐Fetoprotein. Canadian Respiratory Journal. 11(7). 504–506. 23 indexed citations
19.
Yamagata, Toshiyuki, Yuko Yamagata, Masanori Nakanishi, et al.. (2002). THE IMPACT OF PHORBOL ESTER ON THE REGULATION OF AMILORIDE-SENSITIVE EPITHELIAL SODIUM CHANNEL IN ALVEOLAR TYPE II EPITHELIAL CELLS. Experimental Lung Research. 28(7). 543–562. 8 indexed citations
20.
Akamatsu, Keiichiro, et al.. (1998). [Squamous cell lung cancer with minimal-change nephrotic syndrome].. PubMed. 36(12). 1032–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Boita Breakdown of academic impact, for papers by Astrid Doerner Breakdown of academic impact, for papers by Patricia P. Ogger Breakdown of academic impact, for papers by Fotios Drakopanagiotakis Breakdown of academic impact, for papers by Kiran Dhillon Breakdown of academic impact, for papers by Bruno Iovene Breakdown of academic impact, for papers by Karen J. Keeran Breakdown of academic impact, for papers by C. M. Doerschuk Breakdown of academic impact, for papers by Hansvin Bunjhoo Breakdown of academic impact, for papers by Berivan Bıtık
Rankless by CCL
2026